论文部分内容阅读
众所周知,利血平、安体舒通等药物治疗可并发男性乳房增生症。本文介绍30例由钙通道阻滞剂治疗所致的男性乳房增生症。11例50～74(平均59)岁的男性忠者,据报道在长期用硝苯吡啶治疗(平均11个月)后引起乳房增生症,用药剂量为20～120mg/d。虽然有多例同时使用多种药物治疗,且已知其中有些药物是与男性乳房增生症有关,但有7例当停用硝苯吡啶而又继续应用其它药物治疗时,即感到症状有所改善,1例病人在再次开始应用硝苯吡啶治疗后,又再发生乳房增生。1例因单侧乳房增生住院行左侧乳房切除术;1例双侧
As we all know, reserpine, spironolactone and other drug treatment can be complicated by male breast hyperplasia. This article describes 30 cases of male breast hyperplasia caused by treatment with calcium channel blockers. Eleven male loyalty patients aged 50-74 years (mean age 59) were reported to develop breast hyperplasia at long-term nifedipine treatment (mean 11 months) at doses of 20 to 120 mg / day. Although there are many cases where multiple medications are used at the same time and some of them are known to be associated with male breast hyperplasia, 7 patients experienced an improvement in symptoms when nifedipine was discontinued while other medications were discontinued , 1 patient again started nifedipine treatment, and then recurrence of breast hyperplasia. One case left unilateral mastectomy due to unilateral breast hyperplasia; one case bilateral